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KEY MESSAGES: 
 There is an increasing body of evidence that patients with chronic gastrointestinal dis-
ease have brain structural abnormalities in areas linked to the pain network. 
 Magnetic resonance imaging, whole brain volumetry, cortical thickness analysis and 
voxel based morphometry were used to investigate structural brain differences in Di-
verticular Disease (DD) patients for the first time. In particular differences between 
High Somatization DD (HSDD) and Low Somatization DD (LSDD) patients (as char-
acterized using the Patient Health Questionnaire 12, PHQ12-SS) were investigated.  
 The structural brain differences highlighted in this work suggest that these patient 
groups differ in terms of pathophysiology. Increased understanding will help direct 
pharmacological and psychological interventions in this widespread disease. 
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Abstract 
Background   
Recent studies have shown that the brain of patients with gastrointestinal disease differ both 
structurally and functionally from that of controls. Highly somatizing diverticular disease 
(HSDD) patients were also shown to differ from low somatizing (LSDD) patients functionally. 
This study aimed to investigate how they differed structurally. 
Methods  
Four diseases subgroups were studied in a cross-sectional design: 20 patients with asympto-
matic diverticular disease (ADD), 18 LSDD, 16 HSDD, and 18 with irritable bowel syndrome. 
We divided DD patients into LSDD and HSDD using a cutoff of 6 on the Patient Health Ques-
tionnaire 12 Somatic Symptom (PHQ12-SS) scale. All patients underwent a 1-mm isotropic 
structural brain MRI scan and were assessed for somatization, hospital anxiety, depression, and 
pain catastrophizing. Whole brain volumetry, cortical thickness analysis and voxel-based mor-
phometry were carried out using Freesurfer and SPM. 
Key Results  
We observed decreases in grey matter density in the left and right dorso-lateral prefrontal cor-
tex (dlPFC), and in the mid-cingulate and motor cortex, and increases in the left (19, 20) and 
right (19, 38) Brodmann Areas. The average cortical thickness differed overall across groups 
(P=0.002) and regionally: HSDD>ADD in the posterior cingulate cortex (P=0.03), 
HSDD>LSDD in the dlPFC (P=0.03) and in the ventro-lateral PFC (P<0.001). The thickness 
of the anterior cingulate cortex and of the mid-prefrontal cortex were also found to correlate 
with Pain Catastrophizing (Spearman's ρ=0.24, P=0.043 uncorrected and Spearman's ρ=0.25, 
P=0.03 uncorrected).  
Conclusion & Inferences  
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This is the first study of structural grey matter abnormalities in diverticular disease patients. 
The data shows brain differences in the pain network. 
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(SDD), Sir Peter Mansfield Magnetic Resonance Centre (SPMMRC), thalamus (THAL), visual 
analogue score (VAS). 
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Introduction 
Diverticular disease (DD) of the colon, characterized by mucosal herniation, affects predomi-
nantly those over 65 years old and is associated with considerable morbidity. The incidence of 
DD and its complications are increasing1-3 however our understanding of DD is still incom-
plete. Diverticulosis without symptoms is termed asymptomatic DD (ADD). A significant mi-
nority of patients have recurrent episodes of pain (symptomatic DD, SDD). Chronic pain symp-
toms can be present for prolonged periods of time resulting in an associated reduction in quality 
of life and increased cost to the health service 4, 5.  
Visceral pain pathways involve the enteric nervous plexus, signaling to a variety of 
regions in the brain via afferent tracts through the spine, and back via descending nociceptive 
inhibitory control mechanisms within the brain 6, 7. Key cortical brain regions involved in the 
response to pain include the anterior cingulate cortex (ACC), amygdala (AMYG), hypothala-
mus (HpTH), the posterior, mid and anterior insula (INS) locus coeruleus (LC), periaqueductal 
grey (PAG), prefrontal cortex (PFC) including both dorsolateral and orbitofrontal areas, ros-
troventral medulla (RVM), primary and secondary somatosensory cortices (SI and SII) and the 
thalamus (Thal). There are widespread connections between these areas which are often shown 
to be activated in brain imaging studies of emotion processing touching upon affective, emo-
tional and somatosensory aspects of pain. The descending nociceptive inhibitory control 
(DNIC) network and the PFC8 produce a fronto-limbic regulatory network 9-12. 
Recent work has shown that SDD patients have visceral hypersensitivity to rectal bar-
ostat distension13, 14 which also occurs in irritable bowel syndrome (IBS). In another study 
using rectal barostat distension, SDD patients had a significantly lower pain threshold than 
ADD and healthy volunteers15. In that study mucosal biopsies revealed elevation in RNA ex-
pression of tachykinins and galanin receptors (GALR1 and NK1R), TNF-alpha and IL-6 in the 
SDD group, suggesting that the development of painful DD is associated with these neuro-
chemical changes and low level chronic inflammation15.  Those patients with SDD have also 
been shown to report higher levels of somatization as measured by the Patient Health Ques-
tionnaire 12 Somatic Symptom scale (PHQ12-SS) compared to those with asymptomatic dis-
ease 16. This suggests that both central (psychological) and peripheral factors such as prior 
inflammation and changes in the enteric nervous system play a role in symptom reporting in 
this group 17. Therefore it is possible to stratify these symptomatic patients by levels of soma-
tization as it may be the mechanisms of pain perception are different between these two groups. 
Brain activation imaging studies of visceral pain18 tend to consider acute stimuli to different 
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parts of the gastrointestinal tract and reveal a consistent network response including posterior 
and anterior INS and ACC, S1, regions of the PFC and Thal, some of which have direct ana-
tomical connections as studied with diffusion tensor imaging (DTI) 19.  A recent study of an-
ticipation of somatic pain in DD showed brain activation differences between high and low 
somatizing DD patients 20. In addition to the increasing number of imaging studies showing 
alterations of brain function in gastrointestinal diseases there is increasing evidence that struc-
tural changes can also occur in the brain. Studies in IBS showed grey matter density and cortical 
thickness differences in the anterior cingulate cortex (ACC), mid-cingulate cortex (MCC), me-
dial prefrontal cortex, posterior parietal cortex, orbitofrontal cortex, Thal, (para)hippocampus, 
secondary somatosensory cortex SII, and correlations between the thickness of both the insula 
(INS) and dorsolateral prefrontal cortex (dlPFC) with clinical scores 21, 22. Some of these af-
fected areas correspond well with brain areas found to have structural alterations in chronically 
painful conditions such as ACC, MCC, INS, SII in chronic pancreatitis 23; ACC, dlPFC, pre-
frontal cortex, motor cortex, medial frontal gyrus in fibromyalgia 24, 25; Thal, , MCC, anterior 
INS and dlPFC in chronic pain 26, 27. 
Recent studies have shown structural changes in similar areas also in other gastrointes-
tinal disease groups such as Crohn’s disease and functional dyspepsia patients 28-30. However, 
it is not known if grey and white matter changes occur in symptomatic DD and particularly if 
differences may relate to low (LSDD) or high somatization DD (HSDD). The primary aim of 
this cross-sectional study was to test the hypothesis that HSDD patients differed from LSDD 
patients in a selected number of brain regions commonly identified by brain imaging studies 
related to the pain network:  dlPFC, MCC, motor cortex, frontal superior orbital, SII, INS (an-
terior, posterior, frontal operculum), middle frontal gyrus, temporal pole, ACC, orbitofrontal, 
hippocampus, parahippocampus, posterior parietal and Thal. In particular, we hypothesized 
that HSDD would show increased cortical thickness in regional areas of the prefrontal cortex 
such as dlPFC compared to LSDD. Secondly this study aimed to explore correlations between 
standard clinical scores of anxiety, depression and pain catastrophizing and structural brain 
imaging findings. 
 
Materials and Methods 
Subjects 
Seventy-two participants (24 males, 48 females) between 21 and 75 years of age were recruited 
from the gastrointestinal medicine and surgery clinics and a database of interested patients held 
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at the Nottingham Digestive Diseases Centre (NDDC) NIHR Biomedical Research Unit. All 
participants were screened by a medical doctor or a research nurse using a structured telephone 
interview before the study day to confirm the gastrointestinal diagnosis and check for inclusion 
and exclusion criteria (Table 1). We aimed to recruit and study separate groups of patients with 
diverticulosis. These were subdivided according to whether they reported recurrent abdominal 
pain  into those with no pain, labelled asymptomatic (ADD), and those with recurrent pain, 
labelled “symptomatic diverticular disease” (SDD). These SDD were again subdivided accord-
ing to the level of somatization as assessed by the PHQ12-SS into low somatization diverticular 
disease (LSDD) with PHQ12-SS <7 and high somatization diverticular disease (HSDD) pa-
tients with PHQ12-SS>6. We also aimed to recruit a group of patients with a gastrointestinal 
disease of different origin but with similar characteristics. Therefore we recruited a group of 
irritable bowel syndrome (IBS) patients. The symptomatic DD patients exhibited a range of 
bowel habits hence the IBS patients were selected using the recurrent abdominal pain/discom-
fort Rome III criteria without specifying a particular bowel habit. No analysis was taken of the 
specific location of the pain region in the abdomen. All study participants had structural bowel 
imaging as part of their hospital diagnosis, either with flexible sigmoidoscopy or colonoscopy, 
CT, or barium enema. Patients with current acute diverticulitis were not included in the study. 
Patients with prior episodes of acute diverticulitis were included in the study as this is a known 
risk factor for the development of symptomatic disease and therefore excluding these patients 
would introduce a potential selection bias. Patients with prior inflammatory bowel disease were 
also excluded. The final disease subgroups selected had a similar number of participants: 20 
patients with ADD, 18 patients with LSDD, 16 patients with HSDD and 18 patients with IBS. 
The study was approved by the Nottingham Regional Ethics Committee 1 (09/H0403/43) and 
written informed consent was obtained for all participants. The patients were recruited from 
the local gastroenterology clinics endoscopy lists and colorectal surgical clinics. ADD patients 
were recruited from those with no symptoms but one or more colonic diverticulum identified 
on endoscopy, barium enema or CT scan. Symptomatic DD were included if any diverticula 
were present. A total of 426 potential participants were identified and contacted. Respondents 
were initially screened by structured questionnaire over the phone, leading to the enrollment of 
the 72 patients studied here. Recruitment started in February 2010 and completed in September 
2011. 
 
Symptoms questionnaires 
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Psychological factors can be present in symptomatic DD 17. The patients completed a number 
of validated questionnaires to assess their levels of anxiety, depression and somatization of 
symptoms. The hospital anxiety and depression scores (HAD)31 and pain catastrophizing score 
(PCS)32 were used. Somatization was assessed using the Patient Health Questionnaire 12 So-
matic Symptom scale (PHQ12-SS) 16, 33, an adaptation of the standard PHQ15 without the as-
sessment of the gastrointestinal symptoms. Patients are considered to have abnormal values if 
they score more than 6 on the scale 16. The DD patients were therefore divided into low soma-
tization (LSDD) and high somatization (HSDD) if they had a PHQ12-SS up to 6 (LSDD) or 7 
and higher (HSDD).  
 
MRI Protocol 
MRI was performed on a Philips 3T Achieva MRI scanner at the Sir Peter Mansfield Imaging 
Centre, using 8-channel receive head coil. A three-dimensional, gradient-echo, T1-weighted 
(MPRAGE) sequence was used to acquire sagittal anatomical images of the whole brain, ac-
quired and reconstructed at 1 mm3 spatial resolution. The sequence employed a repetition time 
(TR) of 8.2 ms, echo time (TE) of 3.8 ms, 8° flip angle, TI of 960 ms, linear phase encoding 
order with data acquired with a 256256 matrix. 
 
MR image quality control 
The MRI scans were first inspected by AP and a record was made of those artifacts that could 
affect image processing, such as movement noise, susceptibility effects or Gibbs artifacts. The 
results of all volumetric, cortical thickness and voxel based morphometry analyses were quality 
controlled by AP: scans inadequately processed were either re-analyzed or excluded. 
 
Whole Brain Volumetry and Cortical Thickness Analysis 
Freesurfer 34 was used to estimate the global grey and white matter volume, as well as global 
and regional cortical thickness averages. For each patient, the standard, recommended Free-
surfer pipeline was run. Briefly, scans were first corrected for intensity inhomogeneity and 
skull stripped before being projected to Talairach space, where grey matter, white matter and 
a variety of structures were segmented to form tissue maps. These were then triangulated, op-
timized for the location of the tissue boundaries, corrected for topological anomalies and used 
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to calculate local, regional and global thickness measurements, which were then averaged 
across the hemispheres. 
 
Voxel Based Morphometry (VBM) 
Statistical Parametric Mapping (SPM) software package version 12 was used to assess local 
morphological differences between low and high somatization patients in terms of grey matter 
density. The VBM analysis was conducted using the high-precision DARTEL approach rec-
ommended by Ashburner 35. Scans were first manually corrected for position and orientation. 
Grey and white matter tissues maps were then generated and imported into the DARTEL tool, 
in order to create an unbiased, cross group template, to which all scans were precisely regis-
tered. The group-specific template was then registered to the SPM's standard template in Mon-
treal Neurological Institute (MNI) space, which made it possible to project all grey matter maps 
onto the MNI space, whilst ensuring excellent correspondence across patients. Finally, the 
maps were smoothed with a Gaussian kernel of 8mm full width half maximum. A between-
subject t-test was carried out between LSDD and HSDD patients on the modulated smoothed 
maps, with age, gender, BMI and the total cranial volumes obtained above as covariates, in 
accordance with the literature. As an extra quality control process, tissue volumes obtained 
with VBM (by integrating over the modulated tissue maps) were compared to those obtained 
with Freesurfer. 
 
Statistical analysis 
All statistical analyses were performed in SPSS (IBM SPSS Statistics, Version 22.0. Armonk, 
NY). 
We used one-way, independent-sample ANOVA and ANCOVA analyses to compare 
demographic characteristics as well as volumetric and thickness measurements at the global 
and regional level across patient groups. We focused on those regions identified a priori from 
the literature, as discussed in the Introduction, i.e. various sub-structures of the cingulate gyrus 
(ACC, anterior, posterior and dorsal MCC, PCC), prefrontal cortex (dlPFC, MPFC, vlPFC), 
and the insula. We systematically ran all post-hoc pair-wise comparisons, which were corrected 
for multiple comparisons with the conservative Tukey HSD test.  
Since clinical characteristics deviated substantially from a normal distribution they 
were compared across groups using non-parametric independent-samples Kruskal-Wallis tests. 
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We ran all post-hoc pair-wise comparisons using Dunn’s tests, corrected for multiple compar-
isons with the 5% False Discovery Rate. Finally, we used Spearman's ρ to correlate thickness 
measurements and clinical characteristics. 
In terms of VBM, a between-subject t-test was carried out between LSDD and HSDD 
patients on the modulated smoothed maps, with age, gender, BMI and the total cranial volumes 
as covariates, in accordance with the literature. The statistical comparisons were corrected for 
multiple comparison using first the standard Random Field Theory (RFT) cluster approach 36 
and then a more liberal approach (clusters larger than 20 voxels with uncorrected threshold at 
the voxel level of 0.001) where no cluster survived the RFT threshold. 
We used α=0.05 as the threshold for significance and reported 95% confidence intervals 
and η2 effect sizes where appropriate. The statistical review of the study was performed by a 
biomedical statistician. 
 
Results 
All volumetric and thickness analyses were successful therefore no data were discarded. 
 
Clinical Characteristics 
Demographics and clinical information for each patient group is provided in Table 2. One-way, 
independent-sample ANOVAs showed that patients differed in terms of age (F=12.4, P<0.001, 
partial η2=0.35), with IBS patients being significantly younger than others (IBS<ADD: 
P<0.001, CI95%=[-24.58,-9.00]; IBS<HSDD: P=0.03, CI95%=[-17.06,-0.58]; IBS<LSDD: 
P<0.001, CI95%=[-22.38, -6.40]). 
Independent-Samples Kruskal-Wallis tests showed statistical differences across patient 
groups in terms of Somatic Symptom Severity (2=33.18, P<0.001, η2=0.47), Depression 
(2=12.6, P=0.006, η2=0.18), and Anxiety (2=8.66, P=0.03, η2=0.12), but much less so in 
terms of Pain Catastrophizing (2=3.21, P=0.36, η2=0.05). In the first two cases, patients with 
HSDD had higher means than patients with LSDD with the post-hoc Dunn’s P values at <0.001 
and 0.03, respectively. We also found the following remarkable differences: IBS>ADD 
(P<0.001), IBS>LSDD (P=0.006), and ADD<HSDD (P<0.001) in terms of Somatic Symptom 
Severity; and ADD<HSDD (P=0.006) in terms of Depression. 
 
Whole Brain Results 
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The correlation between tissue volumes assessed with Freesurfer and SPM were high: r=0.82 
(P<0.001) for grey matter and r=0.94 (P<0.001) for white matter. 
The one-way ANCOVA showed a substantial effect of age on the total amount of grey matter 
(P<0.001, partial η2=0.15), and on the total amount of white matter (P=0.008, partial η2=0.11), 
and a reduced effect on average thickness (P=0.054, partial η2=0.06), as can be qualitatively 
observed on Figure 1. No tissue volume differences across groups passed the significance 
threshold when adjusting for age, and no interaction either. However, mean cortical thickness 
differed substantially across groups (F=5.733, P=0.002, η2=0.21). Post-hoc comparisons 
showed IBS>ADD (P=0.002, CI95%=[0.03,0.15]) and IBS>LSDD (P=0.01, CI95%=[0.01,0.14]). 
Using age as a covariate of no interest abolished those differences. 
 
Region of Interest Results 
We first report the differences across groups in terms of regional thickness averages for those 
specific structures we identified in the introduction. 
In the cingulate cortex, there were differences in (a) the pMCC (F=2.756, P=0.049, η2=0.11), 
though no post-hoc comparisons survived correction for multiple comparisons, and (b) the PCC 
(F=3.304, P=0.02, η2=0.13) with post-hoc comparisons showing that HSDD>ADD (P=0.03, 
CI95%=[0.01,0.22]). 
In the prefrontal cortex, differences were detected in (a) the dlPFC (F=4.56, p=0.006, η2=0.17) 
with post-hoc comparisons showing that HSDD>LSDD (P=0.03, CI95%=[0.01,0.16]) and (b) 
the vlPFC (F=4.232, P<0.001, η2=0.16) with post-hoc comparisons showing that IBS>ADD 
(P=0.01, CI95%=[0.02,0.18]) and IBS>LSDD (P=0.03, CI95%=[0.01,0.17]). 
We also saw differences in the insula (F=2.855, P=0.04, η2=0.11) with post-hoc comparisons 
showing that IBS>LSDD (P=0.037, CI95%=[0.01,0.24]). 
No statistically significant differences across groups were found for the following (sub-) struc-
tures: ACC, aMCC, dPCC and mPFC (see Table 3). However, the thickness of the ACC and 
the mPFC both correlated with Pain Catastrophizing score (Spearman's ρ=0.24, P=0.043 un-
corrected and Spearman's ρ=0.25, P=0.031 uncorrected, respectively). 
 
In terms of voxel based morphometry, no cluster survived the random field theory threshold 
when age, gender, BMI and total cranial volume were used as covariates. However, there were 
a number of clusters larger than 20 voxels with uncorrected threshold at the voxel level 0.001 
that showed a difference in grey matter density. We report here results for the LSDD versus 
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HSDD contrast since it is the focus of our study; please refer to supplementary table S1 for the 
complete set of VBM results.  
We observed areas with increased gray matter density for HSDD patients w.r.t. LSDD patients 
in the cingulate cortex (MCC), in the pre-frontal cortex (dlPFC), and in the frontal, soma-
tosensory and motor cortices. Areas with decreased density were observed in the frontal, oc-
cipital and temporal cortices (see Figure 2). 
 
Discussion  
 
This is the first study of structural brain grey matter abnormalities in SDD. The data support 
our hypothesis of structural brain differences in HSDD patients compared to LSDD and in parts 
of the hypothesized network response, including MCC, dlPFC, INS, motor and frontal superior 
orbital cortices. The current focus on the pathophysiology of symptomatic diverticular disease 
has been on the role of prior inflammation in the form of acute diverticulitis and ongoing low 
grade inflammation 15. However recognition of the role of alterations in central processing both 
in the anticipation and response to painful stimuli in this group of patients is providing new 
insights into the pathophysiological mechanisms responsible for symptom reporting 20. 
In IBS patients the INS and MCC were shown to have more stress-induced activation 
during rectal stimulation and reduced modulation of INS activity during relaxation compared 
to healthy volunteers37. This suggests that anxiety and depression may play a role in altered 
pain processing. Circuit interaction may be present in DD and be amenable to pharmacological 
or psychological intervention38. Patients with SDD are more likely to report higher levels of 
anxiety and depression on the Hospital Anxiety and Depression Scale 17. During rectal stimu-
lation, IBS patients also show modulation of INS, MCC, VL-PFC, but reduced modulation of 
INS 37. Indeed these areas were highlighted in our recent study of anticipation of thermal pain 
in DD 20. This suggested that the SDD group and the IBS group may have greater emotional 
awareness of the painful stimuli and that this may influence stimulus perception possibly via 
increased MCC and aINS connectivity within a “salience network” 39. 
The prefrontal cortex is involved in high level appraisal of anticipated painful events 40 
and emotional awareness 41, expectation and anticipation of pain42. In anorexia nervosa, greater 
activation of the DL-PFC and cingulate was found compared to healthy women undergoing 
anticipated painful heat stimuli43. Fibromyalgia patients showed increased activation of the 
PAG, posterior parietal cortex and DL-PFC during anticipation of pain44.  In our functional 
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MRI study greater DL-PFC deactivation was seen in response to anticipation of pain in the 
ADD and the LSDD patients compared to HSDD and IBS 20. 
In patients with chronic pain the cortical thickness45, 46 is altered in various areas, and 
some abnormalities can be reversed by analgesia or symptom improvement. Grey matter 
changes have also been reported in other pain matrix regions in chronic pain conditions such 
as the amygdale, hippocampus, post central and superior frontal gyri, INS, prefrontal and 
ACC22, 24, 47-49. In fibromyalgia these changes also correlate with disease duration and age50. In 
IBS changes in grey matter thickness have also been reported, with the hippocampus having 
thickened grey matter while the mid-cingulate cortex was thinned. The insular regions also 
showed altered thickness, with a reduction for IBS patients with a short duration of symptoms 
and increased in those who had long term pain 21. White matter changes have also been detected 
in thalamo-cortical tracts and insular regions47, 49, 51. However similarities and differences in 
the regions affected have been seen between different conditions52-54. There is also suggestion 
that effective treatment may reverse these changes in some chronic pain 26. 
In our patients the ACC and mPFC sub-structures significantly correlated with Pain 
Catastrophizing scores. Pain catastrophizing is a ‘negative cognitive–affective response to an-
ticipated or actual pain’55. Catastrophizing, may be been linked with activity in the cerebellum 
and mPFC (anticipation), dorsolateral PFC and dACC (attention) and lentiform nuclei56. It can 
be associated with anxiety and depression hence assessing possible correlation of cortical struc-
tures with these scores is valuable.  In our recent study of anticipation of pain in DD the HSDD 
and IBS groups showed areas of correlated activity with PCS scores 20. It is worth noting that 
despite having more days with pain the changes in HSDD and IBS patient’ cerebral cortex  
were remarkably similar, suggesting that anxiety and catastrophizing drive the changes more 
than just pain sensation. 
It was not entirely surprising that whole brain volumetry showed an effect of age on 
cortical thickness. The limited sample size and the comparisons made only between patient 
groups, not against a healthy control group, meant that small whole brain volumetry differences 
did not survive the correction for multiple comparisons. Hypothesis driven regional volumetry 
and VBM allowed more precise assessment of differences between our groups. Another limi-
tation of this study was that the IBS patients are younger than the DD groups which was ex-
pected considering the typical IBS phenotype. There was also an imbalance in gender between 
ADD and the other groups. 
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Conclusions 
In conclusion, whole brain volumetry, cortical thickness analysis and voxel based morphome-
try are effective tools to investigate structural brain differences in DD and in particular differ-
ences between high somatization DD (HSDD) and low somatization DD (LSDD) patients. The 
structural brain differences highlighted in this work suggest that these patient groups have dif-
ferences in pathophysiology. Increased understanding of DD is important since DD is the 5th 
most costly gastrointestinal condition in the USA after gastro-oesophageal reflux disease, 
gallbladder disease, colorectal cancer and peptic ulcer disease57. Previous therapies have been 
dominated by a surgical approach directed towards the peripheral causation of symptoms. 
However our findings suggest directing pharmacological and psychological interventions 
aimed at altering pain processing may help to reduce the cost and burden of DD, which is likely 
to increase further as the population age 3, 58, 59. 
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Tables  
 
Table 1: Inclusion and Exclusion criteria 
 
 Inclusion criteria 
Participants must have either  Symptomatic diverticular disease with short-lived recurrent 
abdominal pain on 3 or more days a month and at least one or 
more colonic diverticulum identiﬁed on endoscopy, barium 
enema, or CT scan 
 Asymptomatic diverticular disease, with no abdominal pain 
and at least one or more colonic diverticulum identiﬁed on en-
doscopy, barium enema or CT scan 
 Irritable bowel syndrome, which has been diagnosed by a gas-
troenterologist at the hospital using ROME II or III criteria 
Age 18–85 years 
Handedness  Right 
Informed consent Yes 
 Exclusion criteria 
General  Pregnant or lactating women 
 Severe co-morbidity; for example, heart failure, respiratory 
failure, alcoholism, or drug dependence 
 Participation in any other study on Nottingham University 
campus in the last 3 months 
 No restrictions on the use of HRT, contraceptives medications, 
or timing of menstrual cycle with the study day were imposed 
Metallic implants or objects  Cardiac pacemaker 
 Implanted cardiac deﬁbrillator 
 Metallic heart valves 
 Aneurysm clips 
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 Carotid artery vascular clamp 
 Neurostimulator 
 Insulin or infusion pump or implanted drug infusion device 
 Non-removable cochlear, otologic, or ear implant 
 Shot or shrapnel inside the body 
 Metallic fragments in the eye 
Medications  Inability to stop NSAIDs (non-steroidal anti-inﬂammatory 
agents), antibiotics or immunosuppressant drugs or taking an-
tiepileptic, gabapentin, long-term opiates, or antipsychotic 
medications 
 Participants taking ondansetron were included in the study, 
but the medication was not taken until after the study 
 No exclusions for patients taking antihypertensive medica-
tions, diuretics, alcohol, or caffeine prior to the study 
Inﬂammatory conditions Presence of other gastrointestinal conditions such as ulcerative coli-
tis, Crohn’s disease and Celiac disease, malignancy, cirrhosis, cur-
rent hematological malignancy, untreated peptic ulcer disease, Poly-
myalgia rheumatic 
Abdominal surgery Previous abdominal surgery (other than appendectomy, hysterec-
tomy, cholecystectomy and sterilization, hernia repair) 
Neurological conditions Previous diagnosis of neurological conditions, for example, stroke, 
cerebral malignancy, essential tremor, Parkinson’s disease and Par-
kinson plus syndromes, motor neuron disease, dementia, storage dis-
orders, Wilsons disease etc. Peripheral neuropathy (e.g., diabetic, al-
cohol, stroke) 
Other Claustrophobia, broken skin 
 
  23 
Table 2: Patients demographics and clinical scores (mean±SD)  
 Patient group 
 ADD LSDD  HSDD  IBS 
n= 20 18 16 18 
Gender 10M, 10F 6M, 12F 4M, 12F 4M, 14F 
Age (years) 64±7 61±8 56±10 47±11 
BMI (kg/m2) 27±4 29±6 29±4 26±4 
PHQ12-SS 3±3 4±2 8±2 7±4 
Pain catastro-
phizing 
11±10 10±8 16±14 16±10 
HAD-Anxiety 5±3 6±3 9±4 9±5 
HAD-Depres-
sion 
3±2 4±4 6±3 5±4 
Previous diver-
ticulitis 
10% 39% 31% 0% 
Bowel fre-
quency (/day) 
1.8±0.7 1.7±0.8 2±2 2±2 
Days per month 
of abdominal 
pain 
0.5±0.7 12±11 18±11 11±9 
ADD: asymptomatic diverticular disease 
LSDD: low somatization diverticular disease  
HSDD: high somatization diverticular disease 
IBS: irritable bowel syndrome 
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Table 3: Cortical thickness results comparing all groups for the selected (sub-) structures 
(see Introduction) 
Cortex (Sub-) structure of interest Contrast (p<0.05) 
prefrontal 
dlPFC HSDD>LSDD (P=0.03) 
vlPFC 
IBS>ADD (P=0.01) & 
IBS>LSDD (P=0.03) 
mPFC no group difference 
cingulate 
ACC no group difference 
   aMCC no group difference 
   pMCC group difference only 
PCC HSDD > ADD (P=0.02) 
   dPCC no group difference 
insular insula IBS>LSDD (P=0.037) 
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Table 4: Voxel-based morphometry (VBM) results comparing HSDD and LSDD 
Contrast Cortex Region 
MNI  
coordinates 
(x, y, z)  
Peak T 
HSDD > 
LSDD 
prefrontal 
L & R middle frontal gyrus, 
dlPFC 
(45,12,43) 4.09 
(33,39,42) 4.07 
(42,23,55) 3.83 
(-40,35,42) 3.67 
frontal R superior frontal gyrus (6,35,63) 4.06 
cingulate 
L & R median cingulate gy-
rus (MCC) 
(12,39,31) 3.75 
(10,23,45) 3.74 
(-14,15,37) 3.57 
somatosensory R pre/post-central gyrus (32,-27,75) 3.47 
motor L supplementary motor area (-10,-1,60) 3.86 
LSDD > 
HSDD 
frontal L middle frontal gyrus (-51,-58,-5) 4.43 
occipital L & R middle occipital 
(51,-76,3) 4.12 
(-52,-84,9) 3.91 
(-48,-78,12) 3.35 
temporal 
L & R middle and inferior 
temporal 
(66,-3,-30) 4.04 
(-60,-25,-17) 3.92 
(48,6,-32) 3.79 
(-60,-30,-30) 3.64 
LSDD: low somatization diverticular disease  
HSDD: high somatization diverticular disease 
MNI: Montreal Neurological Institute 
dlPFC: dorso-lateral pre-frontal cortex 
MCC: median cingulate cortex 
L: Left, R: Right 
Region names standardized according to the Online Brain Atlas Reconciliation Tool 
(OBART) 
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Figure Legends 
 
Figure 1. Average thickness, grey and white matter volumes as a function of age. Aver-
age thickness, gray and white matter volumes as a function of age, for each of the four patient 
groups. ADD: asymptomatic diverticular disease, LSDD: low somatization diverticular dis-
ease, HSDD: high somatization diverticular disease, IBS: irritable bowel syndrome. 
 
 
 
Figure 2. Voxel-Based Morphometry (VBM) results. Clusters (red) larger than 20 voxels 
with uncorrected threshold at the voxel level 0.001 for (a) HSDD > LSDD, and (b) LSDD > 
HSDD. LSDD: low somatization diverticular disease, HSDD: high somatization diverticular 
disease. 
 
 
 
 
 
 
 
 
 
 
